CAS 1429755-57-6

Product Name:(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide

IUPAC Name:1-{3-cyano-4-[(E)-[(dimethylamino)methylidene]amino]phenyl}-3-(1-hydroxy-2-methylpropan-2-yl)thiourea

Packing Unit	Available Stock	Price($)
CM329512-250g	in stock	țƀȁƻ
CM329512-500g	in stock	ȬŴǊƙ
CM329512-1000g	in stock	ȁɅțŴ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1429755-57-6 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1429755-57-6; Molecular Formula:C15H21N5OS; Melting Point:-; Smiles Code:CN(C)/C=N/C1=CC=C(NC(NC(C)(C)CO)=S)C=C1C#N; Density:

: Catalog Number:CM329512; Molecular Weight:319.43; Boiling Point:; MDL No:; Storage:Keep in a tight container and store at abient temperature

: Tucatinib; In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.